L. Dahm, C. Ott, J. Steiner, B. Stepniak, B. Teegen et al., Seroprevalence of autoantibodies against brain antigens in health and disease, Ann Neurol, vol.76, pp.82-94, 2014.

S. Doss, K. P. Wandinger, B. T. Hyman, J. A. Panzer, M. Synofzik et al., High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types, Ann Clin Transl Neurol, vol.1, pp.822-854, 2014.

M. S. Zandi, S. R. Irani, B. Lang, P. Waters, P. B. Jones et al., Disease-relevant autoantibodies in first episode schizophrenia, J Neurol, vol.258, pp.686-694, 2011.

T. A. Pollak, K. Beck, S. R. Irani, O. D. Howes, A. S. David et al., Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications, Psychopharmacology, vol.233, pp.1605-1626, 2016.

J. Heine, H. Pruss, T. Bartsch, C. J. Ploner, F. Paul et al., Imaging of autoimmune encephalitis-Relevance for clinical practice and hippocampal function, Neuroscience, vol.309, pp.68-83, 2015.

C. G. Bien, A. Vincent, M. H. Barnett, A. J. Becker, I. Blumcke et al., Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis, J Neurol, vol.135, pp.1622-1660, 2012.

A. Al-diwani, A. Handel, L. Townsend, T. Pollak, M. I. Leite et al., The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data, Lancet Psychiatry, vol.6, pp.235-281, 2019.

J. Dalmau, A. J. Gleichman, E. G. Hughes, J. E. Rossi, X. Peng et al., Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol, vol.7, pp.1091-1099, 2008.

C. Hammer, B. Stepniak, A. Schneider, S. Papiol, M. Tantra et al., Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on bloodbrain barrier integrity, Mol Psychiatry, vol.19, pp.1143-1152, 2014.

B. R. Lennox, E. C. Palmer-cooper, T. Pollak, J. Hainsworth, J. Marks et al., Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a casecontrol study, Lancet Psychiatry, vol.4, pp.42-50, 2017.

K. Pathmanandavel, J. Starling, V. Merheb, S. Ramanathan, N. Sinmaz et al., Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children, Biol Psychiatry, vol.77, pp.537-584, 2015.

P. Fusar-poli, G. Deste, R. Smieskova, S. Barlati, A. R. Yung et al., Cognitive functioning in prodromal psychosis: a metaanalysis, Arch Gen Psychiatry, vol.69, pp.562-71, 2012.

D. O. Perkins, C. D. Jeffries, B. A. Cornblatt, S. W. Woods, J. Addington et al., Severity of thought disorder predicts psychosis in persons at clinical high-risk, Schizophrenia Res, vol.169, pp.169-77, 2015.

A. Mechelli, A. Riecher-rossler, E. M. Meisenzahl, S. Tognin, S. J. Wood et al., Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study, Arch Gen Psychiatry, vol.68, pp.489-95, 2011.

C. Finke, U. A. Kopp, A. Pajkert, J. R. Behrens, F. Leypoldt et al., Structural hippocampal damage following anti-Nmethyl-D-aspartate receptor encephalitis, Biol Psychiatry, vol.79, pp.727-761, 2016.

C. Finke, U. A. Kopp, H. Pruss, J. Dalmau, K. P. Wandinger et al., Cognitive deficits following anti-NMDA receptor encephalitis, J Neurol Neurosurg Psychiatry, vol.83, pp.195-203, 2012.

C. Finke, U. A. Kopp, M. Scheel, L. M. Pech, C. Soemmer et al., Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis, Ann Neurol, vol.74, pp.284-96, 2013.

F. Bartels, T. Stronisch, K. Farmer, K. Rentzsch, F. Kiecker et al., Neuronal autoantibodies associated with cognitive impairment in melanoma patients, Ann Oncol: Off J Eur Soc Med Oncol/ESMO, vol.30, pp.823-832, 2019.

C. Finke, F. Bartels, A. Lutt, H. Pruss, and L. Harms, High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients, J Neurol, vol.264, pp.1968-77, 2017.

G. Westman, M. Studahl, C. Ahlm, B. M. Eriksson, B. Persson et al., N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis, Clin Microbiol Infect, vol.22, pp.934-974, 2016.

F. Gaughran, J. Lally, K. Beck, R. Mccormack, P. Gardner-sood et al., Brain-relevant antibodies in first-episode psychosis: a matched case-control study, Psychol Med, vol.48, pp.1257-63, 2017.

J. Jezequel, E. M. Johansson, J. P. Dupuis, V. Rogemond, H. Grea et al., Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients, Nat Commun, vol.8, p.1791, 2017.

J. Jezequel, V. Rogemond, T. Pollak, M. Lepleux, L. Jacobson et al., Cell-and single molecule-based methods to detect anti-Nmethyl-D-aspartate receptor autoantibodies in patients with firstepisode psychosis from the OPTiMiSE project, Biol Psychiatry, vol.82, pp.766-72, 2017.

E. Castillo-gomez, B. Oliveira, D. Tapken, S. Bertrand, C. Klein-schmidt et al., All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class, Mol Psychiatry, vol.22, pp.1776-84, 2016.

J. Kreye, N. K. Wenke, M. Chayka, J. Leubner, R. Murugan et al., Human cerebrospinal fluid monoclonal N-methyl-Daspartate receptor autoantibodies are sufficient for encephalitis pathogenesis, Brain: J Neurol, vol.139, pp.2641-52, 2016.

M. Makuch, R. Wilson, A. Al-diwani, J. Varley, A. K. Kienzler et al., N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications, Ann Neurol, vol.83, pp.553-61, 2018.

C. Hammer, M. Zerche, A. Schneider, M. Begemann, K. A. Nave et al., Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder, Mol Psychiatry, vol.19, pp.1054-1060, 2014.

T. A. Pollak, S. Drndarski, J. M. Stone, A. S. David, P. Mcguire et al., The blood-brain barrier in psychosis, Lancet Psychiatry, vol.5, pp.79-92, 2017.

K. Schumberg, M. Polyakova, J. Steiner, and M. L. Schroeter, Serum S100B is related to illness duration and clinical symptoms in schizophrenia-A meta-regression analysis, Front Cell Neurosci, vol.10, p.46, 2016.

K. Aleksovska, E. Leoncini, S. Bonassi, A. Cesario, S. Boccia et al., Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia, PLoS ONE, vol.9, p.106342, 2014.

F. G. Strathmann, S. Schulte, K. Goerl, and D. J. Petron, Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives, Clin Biochem, vol.47, pp.876-88, 2014.

P. Fusar-poli, M. Cappucciati, S. Borgwardt, S. W. Woods, J. Addington et al., Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification, JAMA Psychiatry, vol.73, pp.113-133, 2016.

P. Fusar-poli, I. Bonoldi, A. R. Yung, S. Borgwardt, M. J. Kempton et al., Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk, Arch Gen Psychiatry, vol.69, pp.220-229, 2012.

P. Mcguire, J. R. Sato, A. Mechelli, A. Jackowski, R. A. Bressan et al., Can neuroimaging be used to predict the onset of psychosis?, Lancet Psychiatry, vol.2, pp.1117-1139, 2015.

T. C. Kraan, E. Velthorst, M. Themmen, L. Valmaggia, M. J. Kempton et al., Child maltreatment and clinical outcome in individuals at ultra-high risk for psychosis in the EU-GEI high risk study, Schizophrenia Bull, vol.44, pp.584-92, 2018.

S. L. Hatch, S. Frissa, M. Verdecchia, R. Stewart, N. T. Fear et al., Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study, BMC Public Health, vol.11, p.861, 2011.

P. Bebbington and T. Nayani, The psychosis screening questionnaire, Int J Methods Psychiatr Res, vol.5, pp.11-20, 1995.

A. R. Yung, H. P. Yuen, P. D. Mcgorry, L. J. Phillips, D. Kelly et al., Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states, Aust NZ J Psychiatry, vol.39, pp.964-71, 2005.

D. Lukoff, R. P. Liberman, and K. H. Nuechterlein, Symptom monitoring in the rehabilitation of schizophrenic patients, Schizophrenia Bull, vol.12, pp.578-602, 1986.

N. C. Andreasen, The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations, Br J Psychiatry Suppl, vol.7, pp.49-58, 1989.

R. C. Young, J. T. Biggs, V. E. Ziegler, and D. A. Meyer, A rating scale for mania: reliability, validity and sensitivity, Br J Psychiatry: J Ment Sci, vol.133, pp.429-464, 1978.

S. A. Montgomery and M. Asberg, A new depression scale designed to be sensitive to change, Br J Psychiatry: J Ment Sci, vol.134, pp.382-391, 1979.

M. Schmidt, Rey auditory and verbal learning test: a handbook, Western Psychological Services, 1996.

D. Wechsler, Manual for the Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1981.

K. P. Wandinger, S. Saschenbrecker, W. Stoecker, and J. Dalmau, Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis, J Neuroimmunol, vol.231, pp.86-91, 2011.

S. R. Irani, K. Bera, P. Waters, L. Zuliani, S. Maxwell et al., N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes, Brain: J Neurol, vol.133, pp.1655-67, 2010.

S. R. Irani, S. Alexander, P. Waters, K. A. Kleopa, P. Pettingill et al., Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia, Brain, vol.133, pp.2734-2782, 2010.

F. Dickerson, C. Stallings, A. Origoni, C. Vaughan, S. Khushalani et al., C-reactive protein is elevated in schizophrenia, Schizophrenia Res, vol.143, pp.198-202, 2013.

P. Allen, C. A. Chaddock, A. Egerton, O. D. Howes, I. Bonoldi et al., Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis, Am J Psychiatry, vol.173, pp.392-401, 2016.

H. Witthaus, U. Mendes, M. Brune, S. Ozgurdal, G. Bohner et al., Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia, J Psychiatry Neurosci, vol.35, pp.33-40, 2010.

L. L. Gibson, T. A. Pollak, G. Blackman, M. Thornton, N. Moran et al., The psychiatric phenotype of anti-NMDA receptor encephalitis, J Neuropsychiatry Clin Neurosci, vol.31, pp.70-79, 2019.

P. M. Dingemans, D. H. Linszen, M. E. Lenior, and R. M. Smeets, Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E), Psychopharmacology, vol.122, pp.263-270, 1995.

J. Steiner, B. Teegen, K. Schiltz, H. G. Bernstein, W. Stoecker et al., Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited, JAMA Psychiatry, vol.71, pp.838-847, 2014.

M. S. Kayser, M. J. Titulaer, N. Gresa-arribas, and J. Dalmau, Frequency and characteristics of isolated psychiatric episodes in anti-Nmethyl-d-aspartate receptor encephalitis, JAMA Neurol, vol.70, pp.1133-1142, 2013.

J. Wagner, B. Weber, and C. E. Elger, Early and chronic gray matter volume changes in limbic encephalitis revealed by voxel-based morphometry, Epilepsia, vol.56, pp.754-61, 2015.

J. Wagner, J. A. Witt, C. Helmstaedter, M. P. Malter, B. Weber et al., Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis, J Neurol Neurosurg Psychiatry, vol.86, pp.735-777, 2015.

H. Urbach, B. M. Soeder, M. Jeub, T. Klockgether, B. Meyer et al., Serial MRI of limbic encephalitis, Neuroradiology, vol.48, pp.380-386, 2006.

G. Taniguchi, H. Fuse, Y. Okamura, H. Mori, S. Kondo et al., Improvement in anti-N-methyl-d-aspartate receptor antibody-mediated temporal lobe epilepsy with amygdala enlargement without immunotherapy, Epilepsy Behav Case Rep, vol.10, pp.96-104, 2018.

A. Al-diwani, T. Pollak, A. Langford, and B. Lennox, Synaptic and neuronal autoantibody-associated psychiatric syndromes (SNAps): Controversies and Hypotheses. Front Psychiatry, vol.8, p.13, 2017.

D. J. Dean and V. A. Mittal, Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis, NPJ Schizophr, vol.1, p.14006, 2015.

D. J. Dean, J. S. Kent, J. A. Bernard, J. M. Orr, T. Gupta et al., Increased postural sway predicts negative symptom progression in youth at ultrahigh risk for psychosis, Schizophrenia Res, vol.162, pp.86-95, 2015.

C. Tamagni, E. Studerus, U. Gschwandtner, J. Aston, S. Borgwardt et al., Are neurological soft signs pre-existing markers in individuals with an at-risk mental state for psychosis?, Psychiatry Res, vol.210, pp.427-458, 2013.

J. Planaguma, F. Leypoldt, F. Mannara, J. Gutierrez-cuesta, E. Martin-garcia et al., Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice, Brain: J Neurol, vol.138, pp.94-109, 2015.

H. Ehrenreich, Autoantibodies against the N-methyl-d-aspartate receptor subunit NR1: untangling apparent inconsistencies for clinical practice, Front Immunol, vol.8, p.181, 2017.

D. Velakoulis, S. J. Wood, M. T. Wong, P. D. Mcgorry, A. Yung et al., Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultrahigh-risk individuals, Arch Gen Psychiatry, vol.63, pp.139-188, 2006.

H. Pruss, M. Holtje, N. Maier, A. Gomez, R. Buchert et al., IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment, Neurology, vol.78, pp.1743-53, 2012.

H. Pan, A. A. Steixner-kumar, A. Seelbach, N. Deutsch, A. Ronnenberg et al., Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury, Mol Psychiatry, 2020.

E. Castillo-gomez, A. Kastner, J. Steiner, A. Schneider, B. Hettling et al., The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1

, Ann Neurol, vol.79, pp.144-51, 2016.

T. A. Pollak and B. R. Lennox, Time for a change of practice: the realworld value of testing for neuronal autoantibodies in acute firstepisode psychosis, BJPsych Open, vol.4, pp.262-266, 2018.

A. K. Heye, R. D. Culling, V. Hernandez-mdel, C. Thrippleton, M. J. Wardlaw et al., Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review, Neuroimage Clin, vol.6, pp.262-74, 2014.

J. A. Lieberman, R. R. Girgis, G. Brucato, H. Moore, F. Provenzano et al., Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention, Mol Psychiatry, vol.23, pp.1764-72, 2018.

L. J. Phillips, D. Velakoulis, C. Pantelis, S. Wood, H. P. Yuen et al., Non-reduction in hippocampal volume is associated with higher risk of psychosis, Schizophrenia Res, vol.58, pp.145-58, 2002.

A. E. Simon, M. Gradel, K. Cattapan-ludewig, K. Gruber, P. Ballinari et al., Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome, Schizophrenia Res, vol.142, pp.108-123, 2012.

M. Hauser, J. P. Zhang, E. M. Sheridan, K. E. Burdick, R. Mogil et al., Neuropsychological test performance to enhance identification of subjects at clinical high risk for psychosis and to be most promising for predictive algorithms for conversion to psychosis: a meta-analysis, J Clin Psychiatry, vol.78, pp.28-40, 2017.

T. Ziermans, S. De-wit, P. Schothorst, M. Sprong, H. Van-engeland et al., Neurocognitive and clinical predictors of long-term outcome in adolescents at ultra-high risk for psychosis: a 6-year follow-up, PLoS ONE, vol.9, p.93994, 2014.

G. A. Doody, E. C. Johnstone, T. L. Sanderson, D. G. Owens, and W. J. Muir, Pfropfschizophrenie' revisited. Schizophrenia in people with mild learning disability, Br J Psychiatry: J Ment Sci, vol.173, pp.145-53, 1998.

, 14 ? Birte Glenthøj 15 ? Neus Barrantes-Vidal 16 ? Jim van Os 17,18 ? Bart P. F. Rutten 18 ? Rodrigo A. Bressan 19 ? Mark van der Gaag 20 ? Robert Yolken 21 ? Matthew Hotopf 22 ? Lucia Valmaggia 23, vol.2, p.3